Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls and Predict Early Alzheimer's Disease via Untargeted Lipidomics Analysis

Background and Aim: Alzheimer's disease (AD) is the most common type of dementia and presents with metabolic perturbations early in the disease process. In order to explore biomarkers useful in predicting early AD, we compared serum metabolites among patients suffering different stages of AD. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lumi, Li, Lingxiao, Meng, Fanxia, Yu, Jie, He, Fangping, Lin, Yajie, Su, Yujie, Hu, Mengjie, Liu, Xiaoyan, Liu, Yang, Luo, Benyan, Peng, Guoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365883/
https://www.ncbi.nlm.nih.gov/pubmed/34408722
http://dx.doi.org/10.3389/fneur.2021.704582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365883/
https://www.ncbi.nlm.nih.gov/pubmed/34408722
http://dx.doi.org/10.3389/fneur.2021.704582

Ejemplares similares